Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Prostalmet Plus
- Development stage
- Unknown
- Lead developer
- New Marketlink Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Prostalmet Plus is an oral dietary supplement formulated to support prostate health and manage symptoms associated with benign prostatic hyperplasia (BPH). Developed by New Marketlink Pharmaceutical and its subsidiary New Willore Pharma, each softgel capsule contains a combination of saw palmetto extract (320 mg), zinc (6.4 mg), and lycopene (300 mcg). Saw palmetto acts as a mild inhibitor of 5-alpha-reductase (both type 1 and type 2 isoforms), reducing the conversion of testosterone to dihydrotestosterone (DHT) in prostate tissue to alleviate urinary symptoms. Zinc and lycopene provide essential antioxidant support, protecting prostate cells from oxidative damage and inhibiting disease progression.
- Brand names
- Prostalmet Plus
- Other names
- lycopene + saw palmetto + zincsaw palmetto + zinc + lycopenesaw palmetto, zinc, lycopene
02
Targets
SRD5A1 (Steroid 5-alpha-reductase type 1)SRD5A2 (Steroid 5-alpha-reductase type II)
Beyond the preview
Go deeper on Prostalmet Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prostalmet Plus.